toxo model cram Flashcards
Toxicant:
ii. Toxin:
Toxicant: man made poison introduced into the environment
ii. Toxin: natural poison produced by a living organism
Toxicity
. Toxicosis:
Toxicity: the amount or degree of toxin/toxicity it takes to damage an
organism
iv. Toxicosis: disease state induced by the toxin/toxicant
Toxicology
Nanotoxicology
Toxicology: the branch of science which studies nature, effects, and
detection of poisons
vi. Nanotoxicology: Branch of toxicology which studies the toxicity of
nanoparticles (ultrafine particle between 1-100 nanometres in diameter)
dose/response:
dose/response: any increase in dose will cause a graded increase in
response
1. There are two types of dose-response curves
a. one that describes the graded responses of an individual
to varying doses of the chemical
b. one that describes the distribution of responses to
different doses in a population of individuals
NOAEL:
LOAEL
NOAEL: No observed adverse effect level
iii. LOAEL: Lowest observed adverse effect level
LC50:
LD50:
LC50: Lethal Concentration 50- concentration required to kill 50% of the
population
v. LD50: Lethal dose 50- dose at which 50% of population dies
Acute toxicology
Acute toxicology
- Adverse effects of a substance from an exposure for <24hrs
a. Sub-acute=> 24 hours- 1 month
Chronic toxicology
Chronic toxicology
a. Adverse effects of a substance from an exposure for >3
months
1. Sub chronic= >1-3 months
toxic endpoint
A toxic endpoint is the result of a study conducted to determine how
dangerous a substance is. The data collected from such studies are used
to report the relative toxicity of the compound to various regulatory
agencies and environmental compliance groups. Toxic endpoints can
include mortality, behavior, reproductive status or physiological and
biochemical changes.
Developmental toxicity
Developmental toxicity focuses on pre-natal development of the
embryo or fetus. Toxicity may manifest as death of the embryo or
fetus, abnormal development or birth defects or retardation of
normal growth patterns
Reproductive toxicity
Reproductive toxicity looks at all aspects of fertility. This includes
the reproductive cycle, sexual behavior, gamete (sperm or egg)
production and transport, fertility (including sperm quality and
quantity), pregnancy outcomes, gestation, childbirth, lactation and
maternal behavior. These studies also examine postnatal survival,
growth and development of offspring. Some studies look at
multiple generations to detect heritable effects.
DART studies (developmental and repro studies)
DART studies are conducted to ensure the safety of new life-saving drugs
before they go on the market. They are also used to determine the safety
of pesticides and other household or industrial chemicals. Results of
these studies are used to develop safety guidelines to reduce exposure
risks for different populations, including pregnant women, infants and
young children.
ii. Different types of studies are used to evaluate different aspects of
reproduction and development. Generally, DART studies can be divided
into two types, which can sometimes be combined. (developmental and reproductive)
Regulatory Requirements for DART Studies
Regulatory Requirements for DART Studies
1. In the U.S., the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) have established guidelines for DART studies required for product registration and
approval. Similar regulations are in place in the European Union
(EU) and many other regions around the world. Companies must
present data from DART studies conducted per applicable
regulatory guidelines in order to market and use their products in
these countries.
Pharmaceuticals, DART studies reg requirements
Pharmaceuticals: In the U.S., the FDA approves pharmaceuticals
before they can be marketed. The toxicity tests that are required in
the U.S. are dictated by test guidelines put forth by the
International Conference on Harmonization (ICH).
Three DART tests are required for small molecule pharmaceuticals:
Three DART tests are required for small molecule pharmaceuticals:
Embryo-Fetal Development (EFD),
Fertility and Early Embryonic Development (FEED) and a Pre- and Postnatal Development study (PPN). Combination studies may be performed to reduce the number of animals needed and to obtain results more quickly. (This should be
decided on a case-by-case basis, as it may not be appropriate for a given drug.) For large molecule biopharmaceuticals, such as vaccines and
proteins, other laboratory animal species and study designs may be used.
Pesticides and Industrial Chemicals:
DART testing
Pesticides and Industrial Chemicals: Pesticides and industrial chemicals must also undergo DART testing to detect toxicity to the reproductive
system, including prenatal and postnatal development of the offspring. In the U.S., the EPA requires DART testing for product registration of
pesticides . For industrial chemicals, testing requirements are regulated by
the EPA’s Toxic Substance Control Act (TSCA). The EU has similar DART testing requirements for registration of pesticides and industrial
chemicals, which are described in the test guidelines put forth by the Organization for Economic Cooperation and Development (OECD).
Required DART studies depend on the chemical substance and its intended use and may include developmental toxicity, one- and two-generation reproductive toxicity studies, the extended one-generation reproduction study or reproductive screening tests.
Target site resistance
Target site
1. Historically, the type of resistance that farmers and researchers deal with most often is target-site resistance. Every herbicide has a specific target site in a plant. The herbicide has to bind to that
target site and effectively shut it down in order to kill the weed.
Resistance can occur when changes in the target site stop the herbicide from effectively binding there. One change to the amino acid residue chain in the protein sequence, and all of the sudden you have resistance.”
Target-site mutations are often prompted by repeated applications of the same herbicide site of action. Today, target-site resistance remains the most common type of herbicide resistance seen around the world, encompassing resistance to ALS inhibitors,
ACCase inhibitors and more.
Non-Target-Site resistance
Non-Target-Site
1. On the other end of the spectrum, non-target-site resistance, or metabolic resistance, involves more change in the plant than just at the target site alone. In this type of resistance, weeds develop
the ability to rapidly metabolize, or break down, the herbicide before it can cause significant biotoxic effects to the weed. Once an herbicide is inside a plant, it’s going to try and control it,” says
Hager. “With metabolic resistance, the weed is now behaving like the resistant crop and can rapidly metabolize the herbicide and survive.”
2. Though less common than target-site resistance, metabolic resistance is a concern on the rise.
Mixed associations
Mixed associations
- But whether you’re dealing with target-site resistance or non-target-site resistance, the control method remains the same: tank-mixing multiple herbicide modes of action in each application.
- The probability that a weed will be resistant to two different herbicides combined is less than the probability of the weed being resistant to each herbicide individually.
DNA adduct
A DNA adduct is a segment of DNA bound to a cancer-causing chemical .
This process could be the start of a cancerous cell, or carcinogenesis .
DNA adducts in scientific experiments are used as biomarkers of exposure and as such are themselves measured to reflect quantitatively, for comparison, the amount of carcinogen exposure to the subject
organism. Under experimental conditions for study, such DNA adducts are induced by known carcinogens , of which commonly used is DMBA ( 7,12-dimethylbenz(a)anthracene ). The presence of such an adduct indicates prior exposure to a potential carcinogen, but does not by itself
indicate the presence of cancer in the subject animal.
ADME (Absorption, distribution, metabolism, excretion)= Acronym used to describe pharmacokinetics
Absorption- describes the journey of drug traveling from the site of
administration to the site of action
ii. Distribution- describes reversible transfer of the drug from one location to
another within the body
iii. Metabolism= conversion and breakdown of the drug within the body
iv. excretion= process by which metabolic waste is eliminated from an
organism
Environmental Protection Agency :
Environmental Protection Agency : an independent executive agency, not a Department. The
administrator is a member of the Cabinet
Toxic
Substances Control Act TSCA
The Toxic Substances Control Act of 1976 provides EPA with authority to require reporting, record-keeping
and testing requirements, and restrictions relating to chemical substances and/or mixtures.
Certain substances are generally excluded from TSCA, including, among others, food, drugs,
cosmetics and pesticides. TSCA addresses the production, importation, use, and disposal of
specific chemicals including polychlorinated biphenyls (PCBs), asbestos, radon and lead-based
paint.”
Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)
The Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) provides for federal regulation
of pesticide distribution, sale, and use. All pesticides distributed or sold in the United States
must be registered (licensed) by EPA. Before EPA may register a pesticide under FIFRA, the
applicant must show, among other things, that using the pesticide according to specifications
“will not generally cause unreasonable adverse effects on the environment.’’ FIFRA defines the
term ‘‘unreasonable adverse effects on the environment’’ to mean: ‘‘(1) any unreasonable risk to
man or the environment, taking into account the economic, social, and environmental costs and
benefits of the use of any pesticide, or (2) a human dietary risk from residues that result from a
use of a pesticide in or on any food inconsistent with the standard under section 408 of the
Federal Food, Drug, and Cosmetic Act.’’